-
GSK unveils Target the Future, a global, multi-year programme to help address key challenges affecting the multiple myeloma community
WorldPharmaNews
December 02, 2021
GlaxoSmithKline (GSK) plc today launched Target the Future, an international, multi-year initiative dedicated to advancing innovation and addressing key needs in the multiple myeloma community. The programme will provide education on progress in ...
-
Late cancer diagnoses rise as NHS struggles with COVID-19
PharmaTimes
December 01, 2021
Analyses provided by UK cancer charity Macmillan has provided insights into the repercussions experienced by patients waiting to receive treatment during the COVID-19 pandemic...
-
COVID-19 Booster Shot Helps Vast Majority of Cancer Patients
prnewswire
November 18, 2021
Most cancer patients who had no measurable immune response after being fully vaccinated for COVID-19 were helped by a third vaccine dose, according to a new study by investigators at the Montefiore Einstein Cancer Center...
-
Trillium Therapeutics Receives Final Court Order Approving Arrangement
FirstWordPharma
October 29, 2021
Trillium Therapeutics Inc. ("Trillium" or the "Company") (NASDAQ/TSX: TRIL), a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, is pleased to announce that...
-
NCCN Works with Polish Health Leaders to Improve Cancer Standardization, Coordination, and Outcomes
prnasia
October 25, 2021
The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers in the United States—today announced the publication of new NCCN Guidelines® for Cervical Cancer: Poland Edition.
-
World Liquid Biopsy Markets Report 2021: Liquid Biopsy Progress Delayed by COVID Pandemic but Huge Cancer Screening Opportunity Still Looms - Forecast to 2025
prnewswire
October 13, 2021
The "Liquid Biopsy Markets by Cancer Type and by Usage Type with Impact of COVID-19 Pandemic. Including Executive and Consultant Guides and Customized Forecasting and Analysis 2021-2025" report...
-
AstraZeneca and Oncoshot establish strategic partnership to better streamline recruitment process for cancer clinical trials
prnasia
September 28, 2021
Singapore's cancer population may benefit from improved access to cutting-edge clinical trials through InSite Feasibility - Oncoshot's new digital platform that facilitates...
-
Blood test can detect more than 50 types of cancer
pharmatimes
June 28, 2021
Researchers have developed a blood test able detect more than 50 types of cancer that is accurate enough to be used nationally as a multi-cancer screening test in those at higher risk of the disease, including those aged over 50 with no symptoms.
-
ARPA-H: Biden’s proposed government health agency hopes to cure cancer
pharmaceutical-technology
June 09, 2021
The White House has requested $6.5bn of federal funding for an agency to investigate treatments for cancer and other diseases.
-
Lupin announces achievement of key milestones for its clinical stage MEK inhibitor compound
expresspharma
May 31, 2021
Lupin’s MEK inhibitor compound is planned for clinical development in combination with Boehringer Ingelheim’s KRAS inhibitor pipeline to address KRAS-driven cancers.